EIF2AK4 expression leads to pulmonary vascular remodeling, pulmonary telangiectasia, a proliferation of vascular cells, and an increase in typical metabolites in oxidative stress, which are very important for the physiology and pathology of pulmonary hypertension [44]. The gene discussed is EIF2AK4; the disease is pulmonary hypertension.